Neoantigen Cancer Vaccines

Neoantigen Cancer Vaccines

The Elusive Cancer Vaccine Like unicorns, the fountain of youth and calorie-free chocolate, cancer vaccines have long proven elusive. But the emergence of a new crop of biotech companies makes it clear that a cancer vaccine is no myth. The latest advances in genomics...
Post-translational Modifications In Biotech

Post-translational Modifications In Biotech

Basic Science Meets Application “Post-translational modification” may not be a term you hear every day, but it is critically important to the biotech industry—from understanding how cancer develops to producing biologics. Breaking the term down, we know that: “post”...
Targeting The Cause Of Cystic Fibrosis

Targeting The Cause Of Cystic Fibrosis

Biotech Changes The Game The FDA approval of Vertex Pharmaceutical’s (Boston, MA) Orkambi last week further shifted the paradigm of treating cystic fibrosis (CF) for up to half of its sufferers—moving from a management of symptoms approach to targeting the underlying...